Literature DB >> 4336763

Histological evidence of tumour rejection after active immunotherapy in human malignant disease.

G Taylor, J L Odili.   

Abstract

Active immunotherapy with multiple doses of tumour homogenate incorporated in complete Freund adjuvant was used to treat 12 patients with advanced malignant disease. Evidence of some tumour destruction was observed in 10. Improvement in general clinical condition and the disappearance of symptoms referable to tumour occurred in seven of the patients. The duration of improvement varied considerably. Histological evidence of lymphocytic infiltration, necrosis, and fibrous replacement of tumour tissue is presented.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4336763      PMCID: PMC1787938          DOI: 10.1136/bmj.2.5807.183

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  23 in total

1.  Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.

Authors:  G KLEIN; H O SJOGREN; E KLEIN; K E HELLSTROM
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

2.  Studies in tumor autoimmunity.

Authors:  J W FINNEY; E H BYERS; R H WILSON
Journal:  Cancer Res       Date:  1960-04       Impact factor: 12.701

3.  The role of the reticuloendothelial system in the host reaction to neoplasia.

Authors:  L J OLD; B BENACERRAF; D A CLARKE; E A CARSWELL; E STOCKERT
Journal:  Cancer Res       Date:  1961-10       Impact factor: 12.701

4.  The effect of prior injections of tissue antiserums on the survival of cancer homoiografts in mice.

Authors:  N KALISS; N MOLOMUT
Journal:  Cancer Res       Date:  1952-02       Impact factor: 12.701

5.  A new method of active immunisation to autologous human tumour tissue.

Authors:  P L Wolf; J Vazquez; N P Czajkowski; M Rosenblatt
Journal:  Lancet       Date:  1967-10-28       Impact factor: 79.321

6.  Immunological treatment of leukaemias.

Authors:  G Mathé
Journal:  Br Med J       Date:  1970-11-21

7.  Cellular and humoral immunity to different types of human neoplasms.

Authors:  I Hellström; K E Hellström; G E Pierce; J P Yang
Journal:  Nature       Date:  1968-12-28       Impact factor: 49.962

8.  Active immunotherapy in treatment of acute leukaemia.

Authors:  R J Guyer; D Crowther
Journal:  Br Med J       Date:  1969-11-15

9.  Colony inhibition studies on blocking and non-blocking serum effects on cellular immunity to Moloney sarcomas.

Authors:  I Hellström; K E Hellström
Journal:  Int J Cancer       Date:  1970-03-15       Impact factor: 7.396

10.  Clinical immunologic study of malignant disease: response to tumor transplants and transfer of leukocytes.

Authors:  S H Nadler; G E Moore
Journal:  Ann Surg       Date:  1966-09       Impact factor: 12.969

View more
  5 in total

Review 1.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

2.  Leukaemia-associated antigens in man. Detection by antibodies in maternal sera.

Authors:  P R Cullen; D Y Mason
Journal:  Clin Exp Immunol       Date:  1974-08       Impact factor: 4.330

Review 3.  Immunology of bronchial carcinoma.

Authors:  D A Evans
Journal:  Thorax       Date:  1976-10       Impact factor: 9.139

Review 4.  Tumour immunology and the gut.

Authors:  K C Calman
Journal:  Gut       Date:  1975-06       Impact factor: 23.059

Review 5.  Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review.

Authors:  J C Underwood
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.